A biosensor is a measuring device that includes a probe, a physics-chemistry detector element, and a transducer, as well as a sensitive biological detecting substance or a biological receptor. Biosensor research and development is becoming the most widely studied discipline because biosensors are simple, quick, low-cost, highly sensitive, and highly selective, and they help advance next-generation medicines like individualised medicine and ultrasensitive point-of-care detection of disease markers. Biosensors are increasingly widely used in biomedical diagnostics, as well as a variety of other applications such as point-of-care treatment and illness progression monitoring, environmental monitoring, food safety, drug discovery, forensics, and biomedical research. Biosensors can be developed using a wide variety of ways. Their combination with high-affinity biomolecules allows them to detect a wide range of analytes in a sensitive and selective manner. The rapid advancement of biosensors in recent decades, both in terms of research and product development, is largely due to: (i) advances in miniaturisation and microfabrication technologies; (ii) the use of novel bio-recognition molecules; (iii) novel nanomaterials and nanostructured devices; and (iv) improved interaction between life scientists and engineering/physical scientists.
Title : Eliminating implant infection: 30,000 nanotextured implants in humans with no failure
Thomas J Webster, Interstellar Therapeutics, United States
Title : Information leakage: Types, remedies, and open problems
Julia Sidorova, Centro de Investigación Biomédica En Red Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain
Title : Biotech innovations: Bioengineering potential for novel biomanufacturing systems
Murray Moo Young, University of Waterloo, Canada
Title : Development and characterization of exo-ITC: A fibrous bilayer exosome delivery system for dermatological applications
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico
Title : Targeting noncanonical epitopes in anti-cancer immunotherapy
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Stem cell therapy: An affordable healthcare therapy for various diseases
Anant Marathe, Total Potential Cells (P) Ltd, India